Marinomed Biotech AG Sets Price Range for Capital Increases

Marinomed Biotech AG has announced a price range of EUR 4.90 to EUR 5.20 per new share for a potential capital increase. The plan involves issuing up to 154,053 new shares, constituting a 10% increase in the company's share capital. This capital increase excludes statutory subscription rights and is subject to the approval of the Supervisory Board. Proceeds are intended to finance restructuring costs and business operations.

Additionally, Marinomed Biotech AG is negotiating a second potential capital increase of an equal number of shares, also within the same price range. This second increase similarly excludes statutory subscription rights. Both increases depend on final negotiations and necessary approvals.

Currently, no binding agreements have been made with investors, and further approvals and consents are required. Specifically, the restructuring administrator's consent is pending for both increases.